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Abstract 
 
 
 In 2007, pediatric gastroenterologists from ten practice sites across the U.S. created a 
quality improvement collaborative, now known as ImproveCareNow, to improve the quality of 
care provided to children with inflammatory bowel disease. Despite the face validity and great 
potential of quality improvement collaboratives, investigators do not fully understand how 
improvement happens, including the variables contributing to quality measures and the 
necessary components needed to sustain quality improvement. The purpose of this project was 
to explore perceptions of collaborative participants to identify elements of sustainability.  
We performed qualitative interviews with 16 ImproveCareNow participants as one 
method in a triangulated strategy of measuring collaborative participants‟ perceptions. We 
selected informants from a diverse list of practice types and geographic locations, and asked 
open-ended questions, which we then transcribed and coded.  For this master‟s paper‟s focus 
on sustainability, I extracted participant views of the collaborative‟s most valuable aspects, 
obstacles to participation, and perceptions of variables affecting outcome measures.  
New site participants found practice standardization to be most valuable; existing sites 
named a patient tracking, collaboration, and quality improvement training. New and existing 
sites mentioned time as the biggest obstacle to collaborative participation; existing sites, with 
more experience, also named persuading non-ICN providers to support the effort, and other 
challenges varied by particular ICN activities. Finally, 9 of 12 (75%) informants said that 
collaborative activities were responsible for improved inactive disease rates, and 3 of 12 (25%) 
said the ICN collaborative was partially responsible. When asked if other factors were affecting 
outcomes, 4 of 12 (33%) said no; 2 of 12 (17%) said yes; and 6 of 12 (50%) were uncertain.  
Analyzing in-depth interviews of ICN participants is the first step in understanding what 
health care providers perceive as the value from, benefits of, and challenges to initiating and 
sustaining collaborative quality improvement activities. 
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Perspective/Author’s Note 
 
This master‟s paper represents just a portion of a larger team project that allowed my 
friend and colleague Thomas Runge and me to employ qualitative research tools to examine 
this pediatric IBD collaborative. Working together, we were able to examine the perspectives of 
collaborative participants and explore the literature on quality improvement collaboratives in 
greater depth than either one of us alone could have achieved. Therefore, the work completed 
for the master‟s paper and practicum requirements was a collaborative effort, in which we both 
contributed equally at every stage.  
Although our master‟s project examined the perceptions of participation in a pediatric 
IBD collaborative, I chose to focus on elements of sustainability of particular ICN activities and 
the Improve Care Now (ICN) collaborative itself, while Thomas chose to focus on the practice 
variation and implementation of key ICN activities. We hope to present our combined work, 
including findings not fully represented in our master‟s papers, to the ICN Research Committee 
and we intend to publish our combined results in a peer-reviewed journal. Overall, sustaining 
quality improvement requires systems change and commitment at every level of the health care 
system. 
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Introduction 
 Pediatric inflammatory bowel disease (IBD) represents one of several chronic diseases 
that are the focus of quality improvement efforts in the U.S. Chronic diseases are the leading 
causes of death and disability in the U.S.,1  making their management an important focus of 
quality improvement and prompting the development and utilization of the chronic care model, 
improvement collaboratives, health information technology, pay for performance financial 
incentives, and report cards.2  Recognizing that addressing practice variation is an important 
step in quality improvement, a group of pediatric gastroenterologists from ten centers across the 
country formed the first pediatric IBD quality improvement collaborative in 2007,3  now known as 
ImproveCareNow. Since then, the collaborative has grown to represent 23 sites. As of 2009, 
more than 2,500 patients have been enrolled in a pediatric IBD registry, and data from over 
7,500 visits have been collected and analyzed.4  Preliminary data indicate a rise in the rate of 
disease inactivity from 49% at the beginning of the collaborative to 64% in 2009. Can 
collaborative activities be said to account for any of the improvement in inactive disease?  
Identifying the drivers of outcomes improvement within and outside the collaborative is 
necessary to understanding how quality improvement occurs.  
 Assuring health care quality in the U.S. began more than a century ago when Ernest 
Codman convinced the founders of the American College of Surgeons to adopt a system of 
measuring patient outcomes.5  By the 1960‟s, assessing quality expanded beyond patient 
outcomes. Avedis Donabedian outlined a framework for quality measurement, consisting of 
three components – structures, processes, and outcomes.6  Structural measures are 
characteristics of the setting in which care is delivered. Process measures represent the steps 
health care providers take in the care of a patient. Outcome measures indicate changes that 
occur in a patient‟s health status as a result of a health care intervention. 
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 John Wennberg and Alan Gittelsohn revived the quality of care conversation two 
decades later by introducing the concept of practice variation, after they demonstrated the 
existence of small area practice variations in the utilization of health services and their 
associated costs.7  Unwarranted variation in care may be associated with misuse, underuse, 
and overuse of health care resources and services.8, 9  Performance variation, a type of 
unwarranted variation, is the difference between optimal performance and observed practice.10, 
11  Quality improvement science involves addressing such variation, using methods adapted 
from other industries. For instance, the Institute for Healthcare Improvement based its Model for 
Improvement in large part on W. Edwards Deming‟s approach to management, the System of 
Profound Knowledge.12  
 Quality improvement finally came to public attention when the Institute of Medicine (IOM) 
found that serious and widespread quality problems existed throughout American medicine.8  
and subsequently released its reports To Err is Human in 200013  and Crossing the Quality 
Chasm in 2001.14  The IOM defined quality of care as “the degree to which health services for 
individuals and population increase the likelihood of desired health outcomes and are consistent 
with current professional knowledge.”15  In To Err is Human, the IOM reported that “tens of 
thousands of Americans die each year from errors in their care, and hundreds of thousands 
suffer or barely escape non-fatal injuries.”13  Crossing the Quality Chasm concluded that 
“between the health care we have and the health care we could have lies not just a gap, but a 
chasm.”14  Reviving Codman‟s sense of accountability among clinicians, the IOM reports 
emphasized systemic changes in the health care delivery system to improve health care quality, 
including extensive training of health care providers and the development of tools to measure 
and assess quality improvement. Minimizing variations in practice and carefully collecting data 
on processes of care and outcomes requires multi-level changes to health systems.12, 16, 17    
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Quality improvement collaboratives (QICs) represent one systems-based approach to 
improve health care quality and patient outcomes. In 1998, the Institute for Healthcare 
Improvement developed the Breakthrough Series collaborative model, legitimizing a model for 
quality improvement and spawning new attempts to reorganize and improve care.18, 19  In QICs, 
multidisciplinary teams from different sites work together to develop strategies to improve 
patient care.2  QIC participants receive training in quality improvement, set measurable goals, 
track process and outcomes measures through plan-do-study-act cycles, exchange ideas and 
advice, and generate enthusiasm and commitment to achieving a common goal.20  (Find 
additional information on the origin of quality improvement collaboratives in Appendix 1: Further 
Background on Quality Improvement Collaboratives.) 
Health care providers and administrators have adapted QICs to fit their goals, from 
reducing hospital mortality associated with coronary artery bypass graft surgery21  to lowering 
mean hemoglobin A1c levels in diabetic patients in primary care clinics.22  Despite the face 
validity and growing popularity of QICs, investigators acknowledge the modest quantity and 
quality of evidence supporting collaboratives as an effective intervention.20, 23-25  (Find additional 
information on the effectiveness of quality improvement collaboratives in Appendix 2: Limited 
Systematic Review of Quality Improvement Collaboratives.) 
 
The Need for Quality Improvement in Pediatric IBD 
Inflammatory bowel disease (IBD) affects greater than one million individuals in the U.S., 
including 100,000 children.26  More than 700,000 physician visits, 100,000 hospitalizations, and 
disability for 119,000 patients are attributed to IBD annually.27  IBD also presents a significant 
financial burden, with health care costs associated with adult and pediatric IBD exceeding $1.7 
billion annually in the U.S.26  Furthermore, pediatric IBD poses an additional psychosocial 
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burden on children and their families as children with IBD are at greater risk of difficulties in 
behavioral and emotional functioning.28   
Like many chronic diseases, early studies suggest variation in care among IBD patients. 
In a study of 65 adult patients with IBD, Reddy et al. found that there was suboptimal dosing of 
maintenance medications, prolonged use of corticosteroids, failure to use steroid-sparing 
agents, and inadequate attention to metabolic bone disease and screening for colorectal 
cancer.29  Colletti et al. reported similar variation in care among 246 pediatric patients with 
Crohn‟s disease.3  Clinicians vary in their utilization of diagnostic interventions and treatments, 
including stool tests for pathogens, imaging of the small bowel, following pretreatment protocols 
before initiating thiopurine or infliximab, poor adherence to medication dosing 
recommendations, and inconsistencies in nutritional interventions among severely underweight 
patients.3  As Kappelman et al. noted, “there is a clear need for translating evidence-based 
practices into the actual practice and follow-up provided for patients.”2  
ImproveCareNow (ICN) originated from the Pediatric IBD Network for Research and 
Improvement (PIBDNet), a two-year project funded by the North American Society for Pediatric 
Gastroenterology in 2004 to evaluate variation in care in pediatric Crohn‟s disease.4  After 
publishing its findings in 2009,3 PIBDNet shifted its focus to quality improvement and formed the 
PIBDNet Trailblazer Improvement Collaborative, basing it on the IHI‟s Breakthrough Series 
Model.4  Beginning with ten sites in 2007, ICN has expanded to 23 sites with each bearing the 
costs of an annual participation fee to support the infrastructure of the collaborative, travel to 
semi-annual meetings of all the site teams, and staffing at its site for data collection and entry as 
well as quality improvement projects to redesign care delivery.4  ICN has implemented a number 
of quality improvement activities to decrease variation in care, assess process and outcome 
measures, and track patients more efficiently. Collaborative members believe they have 
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witnessed promising results both in terms of processes of care and outcomes and think that 
practice sites are building sustainable infrastructures.  
 Investigators frequently demonstrate the need to lessen practice variation and improve 
the quality of care in many fields; however, they have a more modest understanding of how 
improvement happens in particular health fields, and know even less about how to sustain that 
improvement. Pediatric gastroenterologists have invested considerable energy, time, and 
finances to improve the quality of care of pediatric IBD patients through a quality improvement 
collaborative. The purpose of this project is to explore and assess the perceptions of 
participants in this preliminarily successful collaborative. Describing elements of sustainability of 
ICN has implications for future health delivery systems in its approach to other chronic diseases. 
I will examine the most valuable aspects of the collaborative, the obstacles to participation, and 
the variables affecting outcome measures perceived by ICN participants. 
Methods 
 
We used the following three methods of analysis to identify and verify perceptions of 
participation in ICN: (1) in-depth structured interviews, (2) a web-based survey of collaborative 
participants (see Appendix 3: Further Methods, and Appendix 6: Survey), and (3) observation of 
participants at an ICN learning session (see Appendix 3: Further Methods). This mixed-method 
analysis allowed us to triangulate our approach to accurately reflect the perceptions and 
characteristics of ICN collaborative participants. The University of North Carolina IRB reviewed 
our research protocols and determined that we were exempt from the consent requirement and 
from further review. 
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In-Depth Structured Interviews 
The purpose of the in-depth structured interviews was to identify what ICN members 
believed were the key values, components, and drivers of the ICN collaborative and improved 
outcomes measures. Using process tracing, a method of obtaining information about well-
defined and specific events and processes, elite interviews can be used to establish what a set 
of people think and to make inferences about a larger population's characteristics and 
decisions.30  Elite interviews were used for additive purposes, or to provide new information that 
advanced the research process;31  for our purposes, we used the information about 
interviewees‟ attitudes, values, and beliefs to develop a web-based survey. 
Our sampling strategy was based on purposive and chain-referral methods, often used 
when randomized selection is not appropriate.30  We selected a sample of participating centers 
that represented geographical diversity, differing lengths of membership in the ICN 
collaborative, and a range of public versus private practice settings. In total, we selected ten 
participating centers from the following hospitals and cities: Pediatric Gastroenterology and 
Nutrition Associates, Las Vegas, NV; Oklahoma University Medical Center, Oklahoma City, OK; 
Children's Hospital of Oakland, Oakland, CA; Nationwide Children's Hospital in Columbus, OH.; 
Maine Medical Center, Portland, ME; Inova Health System, Falls Church, VA; North Carolina 
Children's Hospital, Chapel Hill, NC; The Children's Hospital-Denver, Aurora, CO; Carolinas 
Medical Center, Charlotte, NC; and Children's Hospital Boston, Boston, MA. Seven of these 
sites had participated in the collaborative for more than two years; three were sites about to 
attend their introductory learning session. We contacted two members at each site using a 
standard recruitment message. First, we invited the principal investigator, always a physician at 
each site, whom we asked to identify a non-physician team member whom they felt could 
knowledgeably reflect on their center's experience of ICN membership. The interview protocols 
for existing and new ICN participants are located in Appendices 4 and 5, respectively.  
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At the beginning of each interview, we asked for the participants' permission to be 
recorded with a digital voice recorder and to use direct quotes for purposes of analysis. We 
recorded the interviews and used recorded files and type written notes to transcribe each 
interview. In total, we transcribed 42,780 words, equaling 91 typed pages. We sent each 
respondent his or her own completed transcription. 
 
 Methods for Coding Interviews.  Based on a multi-step analytic method described by 
Philip Bernard,32  two independent investigators (E.P and T.R.) systematically reviewed 
transcripts and notes from 16 interviews and coded them for themes and concepts in an Excel 
spreadsheet. Because interviews consisted of open-ended questions, we used an open coding 
strategy described by Strauss and Corbin33  to construct our codebook. We began with 138 
unique headings based on acquired knowledge and interview questions, which were collapsed 
into 19 larger categories. When new concepts emerged, we added a code heading to reflect 
them. To categorize particular responses, we sought to enter the respondent‟s “frame of 
reference,” as described by Rogers.34  Both investigators discussed and agreed upon 
establishing the final code headings. Then, we (E.P. and T.R.) independently reviewed the 
transcriptions and notes again to complete the codebook. We used 39 final code headings; 
codebook information can be seen in Table 1: Interview Data Collected.  
Upon completion of coding, E.P. and T.R. met to determine the agreement in coding and 
resolve conflicts. Such utilization of multiple coding minimizes the potential biases when 
assigning categories to respondent data, and although intensive in nature, it leads to further 
refinement of code headings 35  and allow for more elaborate and through systematic analysis.36  
We used descriptive statistics to tabulate results in Excel. Kappa statistics for five sets of 
categorization headings are displayed in Table 2. 
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Results 
 
Most Valuable Aspect of the Collaborative 
Seventeen of 18 invited participants from ten sites agreed to be interviewed, and 16 of 
these 17 scheduled and completed the interview. Table 3 lists the interviewees and their 
member sites. Table 4 lists selected site characteristics. One participant refused to be recorded, 
and a second participant's interview was not recorded because of technical difficulties. The 
average interview lasted 24:46 minutes, but ranged from 10:09 to 43:07 minutes.  
A summary of the most valuable aspects of the collaborative perceived by ICN 
participants can found in Table 5. Standardizing practice was the most common response 
among new site participants when they were asked to say what was most valuable to them as 
health care providers from joining the collaborative. One participant mentioned patient tracking 
as the most valuable aspect.  
Participants from existing sites took varying perspectives. Three of the ten existing site 
participants claimed patient tracking was the most valuable aspect of ICN. Patient tracking can 
be summarized as a system that allows clinicians to track their patients‟ disease severity, 
diagnostic tests, nutrition and growth status, medications, and preventive-care measures. These 
participants describe the value of honing in on details of care they may miss otherwise. One key 
informant described the patient encounter when he realized the value of patient tracking: 
I‟ve followed [one patient with ulcerative colitis] for 10 to 15 years…and I would see her about 
every 6 months to a year.... Over two or three years, she lost two to three kilos, …but because 
she didn‟t have …particular symptoms, I really didn‟t pursue it. But once we started up the 
collaborative…and watching nutritional status, …I started saying, „Well, gee wiz, look at this, 
she‟s been going down for years!‟ …I re-evaluated her, and she had active disease, and when we 
started pushing, it became pretty obvious that she hardly ever took her medication. 
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Four existing site participants said that collaboration -- interaction with physician leaders, 
sharing information, and creating a sense of accountability – was the most valuable 
collaborative feature.  For example, one informant describes the most valuable aspect of the 
collaborative as “being [able] to meet with … not only industry leaders and others that care for 
IBD [patients], but those that work in quality improvement as well. Having them meet in one spot 
has been invaluable.” Another participant describes the sharing of information and resources in 
the collaborative: “People may have great ideas that you never thought of, and rather than re-
inventing the things, let‟s adapt what‟s working well for other centers who do really well, while 
not wasting time repeating some of the same mistakes. The three remaining existing site 
participants described quality improvement training resulting in an increased knowledge base 
and resources, as the most valuable aspect of being in the collaborative.  
 
Obstacles to Participation 
ICN participants described encountering a number of obstacles during the 
implementation of particular ICN activities. Table 6 and 7 list barriers described by key 
informants and the frequency they mention them. Among new sites, participants worry that a 
number of factors threaten their participation in ICN quality improvement activities, the most 
common of which is time: three of the four new site informants mention their own time as a 
challenge to ICN participation. One provider expands: “Just seeing the huge volume of emails, 
I‟m going to have to cancel a weekly clinic just to keep up. …The volume of communication 
seems to be quite significant. So, there has to be time, and someone has to pay for that time, 
right?” 
Other barriers included a need for clinic infrastructure, fostering support from others in 
the practice, financial costs, a lack of personnel and resources, and a lack of understanding 
among other providers about what quality improvement is. Financial barriers may be particular 
to the type of institution a provider belongs. One provider says, “Every hospital is having 
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budgetary difficulties to support these research activities. We‟re not part of a university setting, 
so we have to find the money to pay the personnel that will be doing the study, to cover the 
budget for the trips to go and attend the meetings.” 
Providers at existing sites in ICN also worry about similar barriers:  informants 
mentioned seven types of obstacles inherent to different ICN activities. Time was the most 
common obstacle (8 of 12 mentions), followed by earning the support for quality improvement 
from fellow health care providers (7 mentions) and a lack of personnel (5 mentions). 
Transitioning to electronic medical records and taking on too much work initially were two other 
challenges, with 3 mentions each.   A single informant mentioned coordinating schedules and 
obtaining patient/family buy-in for a particular clinic change.  
If we break challenges down by ICN activity, we see indications that particular 
challenges are inherent to the quality improvement activity. Table 8 provides a brief description 
of different ICN activities described by informants, and Table 9 illustrates the number of times a 
particular obstacle was mentioned in terms of a particular ICN activity. Population management, 
a form of patient tracking, was a commonly described collaborative activity and appeared to 
create a variety of challenges for providers, including time commitment, gaining the support of 
other providers, and working through personnel issues, such as a lack of providers or provider 
turn-over, often nurses. Pre-visit planning, the second most commonly described ICN activity, 
presents similar challenges to providers, though obtaining the support from other physicians in 
the practice was the most frequently mentioned barrier. Another notable activity that several 
sites have implemented is instituting an IBD clinic, which presents challenges unlike population 
management and pre-visit planning. Working through logistics and clinic restructuring was more 
commonly mentioned than time and gaining support from other providers.  
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Perceived Collaborative Effectiveness 
 When we asked collaborative members if increased patient remission rates were a result 
of the collaborative, 9 of 12 (75%) of the informants said “yes,” and the remaining 3 said the ICN 
collaborative was partially responsible.  Four of the 12 said that other factors were not affecting 
outcomes; half of participants were uncertain about the role of other influences, and 17% of 
respondents thought that outcomes were attributed to factors beyond collaborative activities.  
Respondents discussed sources of outcomes change: two informants mentioned variation in 
how patients were entered into the database, suggesting that, early on, sick patients were more 
likely to be enrolled given their frequency of clinic visits.  Utilization of more aggressive 
treatment options was also mentioned by two informants.  Subjective variation in scoring of 
disease severity using the Physician Global Assessment; inconsistent participation of other 
physicians at practices; natural stabilization of the course of disease over time, occurring 
independent of the collaborative; and disease characteristics not yet known by the medical 
community were all mentioned once.  
  Discussion 
 
 Performing qualitative interviews of ICN participants is the first step in understanding 
what health care provider perceive as the value, benefit, and challenge to initiating and 
sustaining quality improvement activities in a collaborative. At all points of the collaborative‟s 
evolution, health care providers must perceive that the collaborative and its activities provide 
tangible benefits to a practice. The differing views of the most valuable aspect of ICN by new 
and existing site participants may indicate that one‟s perception of collaborative value changes 
with increasing participation. For instance, new member providers may see a collaborative as 
an approach to establish care guidelines and build consistency in health care practices. 
Because developing Model of Care Guidelines, and measuring their implementation, was an 
 12 
 
early focus of the collaborative, longer-standing members may have shifted their perceived 
value of ICN to patient tracking, collaboration with other providers, and quality improvement 
training. Alternatively, new member providers may not anticipate the value of collaboration, 
patient tracking, and quality improvement training at the onset of their participation.  
Overcoming obstacles to collaborative participation cannot occur until the obstacles are 
identified.  Because participants had not ever been queried about participation challenges in a 
systematic way before we conducted this study, collaborative leaders did not know to what 
extent particular barriers confront providers. Some challenges, such as financial costs, may not 
be surprising, but should be viewed in context of other obstacles facing providers. Sustaining 
quality improvement involves integrating it into the fabric of the practice, and gaining the support 
of non-ICN physicians for ICN is a substantial barrier.  
In addition, challenges encountered by ICN members as they undertake particular ICN 
activities are also important to the sustainability of quality improvement activities. Most providers 
were in agreement about the value of population management and pre-visit planning, but often 
the continuation of these activities at certain sites is threatened by small changes, such as the 
turn-over or unavailability of a key provider.  
Finally, and possibly most importantly, assuring that the collaborative itself is causing the 
increase in patient remission rates, a key outcome measure, is vital to sustaining ICN as an 
effective intervention. At this point, most providers believe the collaborative is the main driver of 
improved outcomes and this perception will likely sustain active collaborative participation and 
propel future recruitment of new sites. However, many ICN members are aware of potential 
confounders of measured outcomes. Though infrequent, participants‟ mention of confounders 
prompts further investigation into what other ICN participants feel may be influencing increasing 
remission rates and to what extent.  Site-to-site variation in the perceptions of potential 
confounders is an important consideration for future quality measures. Overall, to ensure active 
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participation among existing and new members, most participants should agree that ICN is an 
effective approach to improving the quality of care provided to pediatric IBD patients.  
 
Future Directions 
These qualitative interviews serve as the foundation for a web-based survey that will 
allow us to measure more extensively the perceptions of ICN participants. The number of 
interviews completed for this project was not sufficient to make conclusive determinations 
regarding the perceptions of the universe of ICN participants. A web-based survey will allow us 
to reach the universe of providers, including various types of providers affiliated with ICN.  
Two sites have withdrawn from collaborative participation since its inception. Examining 
the perceptions of former ICN members would give us a basis for comparison for several 
variables. For instance, do former ICN site participants feel that the collaborative did not provide 
valuable benefits to them as health care providers? Or, were there particular challenges that 
forced these sites to withdraw? Speculation points to the latter, but interviews with withdrawn 
site members could confirm this conclusion. 
Multidisciplinary care is the basis for many quality improvement efforts, including the 
chronic care model and quality improvement collaborative. However, identifying the differing 
needs and obstacles facing different types of health care providers is also important to 
sustaining cross-disciplinary quality improvement efforts. Measuring the perceptions of other 
members of the IBD care team may shed some light on this question. 
Conclusion 
 Quality improvement collaboratives are one approach to improving patient care, 
particularly with chronic disease management. The ImproveCareNow (ICN) collaborative is a 
network of pediatric gastroenterologists from public and private practices and different 
geographical regions who agreed to share outcomes data and information on processes of care 
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for the purpose of improving the quality of IBD care provided to their patients and families. Many 
investigators agree that reducing practice variation is an important step in quality improvement. 
Despite the great potential of collaboratives, investigators have a modest understanding of how 
improvement happens. In this project, we explored and assessed the perceptions of ICN 
participants about several aspects of the collaborative. In this paper, I presented results of 
qualitative interviews with 16 ICN providers specific to collaborative and quality improvement 
sustainability. For providers to be active members of the collaborative, they must perceive 
particular benefits, and results indicate that participant views of the most important aspect of 
collaborative participation changes over time.  In addition, informants described various 
obstacles to participation in the collaborative itself and a number of its particular activities. 
Implementing and sustaining quality improvement takes much time, money, human resources, 
and provider commitment.  Sustaining quality improvement requires systems change and 
commitment at all levels, at all times.
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Tables and Figures 
Table 1: Interview Data By Domain 
Factor Variables 
Interviewee Name Center Existing/New 
site 
Type of 
provider 
    
General 
Impression 
Improve care 
for patients 
Research 
opportunities 
Interactions, 
accountability 
Leadership, 
training skills 
Developing best 
practices 
Other   
Most 
Valuable 
Aspect 
Patient 
tracking 
Leadership 
training 
Practice 
standardization 
Other     
ICN 
Activities 
Population 
management 
Pre-visit 
planning 
Standardized 
clinic template 
Nutrition & 
growth 
algorithm 
IBD Clinic PDSA’s Multidisciplinary 
team meetings 
Self-
management 
Activity 
Evaluation 
Success Order 
mention 
Obstacles Expectations Implementation HCP’s 
involved 
Practice 
standardization 
Culture 
change 
Determining 
Factors 
Contributing 
to Outcomes 
Opinion of 
ICN 
Confounders 
/Other 
contributors 
to outcomes 
Other factors 
to be 
measured 
     
Obstacles Budget Lack of 
personnel 
Creating a 
culture of QI 
Time Lack of 
leadership 
Infra-
structure 
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Table 2: Kappa Statistics 
Question Kappa 
Q1 – General Impression 0.57 
Q2 – Most Valuable Aspect of Participation 0.83 
Q3 – ICN Activity Categorization 0.82 
Q4 – Outcomes Due to Collaborative 1.00 
Q5 – Potential Confounders 0.62 
 
  
Table 3: Interviewees 
Name Type of 
Practitioner 
Center City, State 
Leslie Higuchi MD Children’s Hospital Boston Boston, MA 
Victor Pineiro MD Carolinas Medical Center Charlotte, NC 
Deborah Neigut MD The Children’s Hospital Aurora, CO 
Diane Redmond Quality 
Improvement 
Specialist 
The Children’s Hospital Aurora, CO 
Sandra Kim MD North Carolina Children’s Hospital Chapel Hill, NC 
Beth McLean RN North Carolina Children’s Hospital Chapel Hill, NC 
Ian Leibowitz MD Inova Health System Falls Church, VA 
Bernadette Diez NP Inova Health System Falls Church, VA 
Mark Integlia MD Maine Medical Center Portland, ME 
Bernadette Ray RN Maine Medical Center Portland, ME 
Wallace Crandall MD Nationwide Children’s Hospital Columbus, OH 
Amy Donegan NP Nationwide Children’s Hospital  Columbus, OH 
Sabina Ali MD Children’s Hospital of Oakland Oakland, CA 
John Grunow MD Oklahoma University Medical Center Oklahoma City, OK 
Howard Baron MD Pediatric Gastroenterology & 
Nutrition Associates 
Las Vegas, NV 
Teresa Carroll NP Pediatric Gastroenterology & 
Nutrition Associates 
Las Vegas, NV 
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Table 4: Selected Site Characteristics 
Table Data Site IBD Patients Enrolled in 
Database 
Direct Academic Affiliation 
  ≤100 >100 Yes No 
Oakland = A A •   • 
Las Vegas = B B •   • 
Oklahoma = C C  • •  
Maine = D D •  •  
INOVA = E E  • •  
CMC = F F •   • 
Nationwide = G G  •  • 
Denver Children's = 
H 
H •    
UNC = I I  • •  
Boston Children's = J J •    
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Table 5: Most Valuable Aspect of the Collaborative Perceived by ICN Participants 
Most Valuable Aspect of a Collaborative Existing Site 
Participants (n=10) 
New Site 
Participants (n=4) 
Patient Tracking 3 1 
Collaboration (Interactions with physician leaders, 
sharing information, creating a sense of 
accountability) 
4 0 
QI training 3 0 
Practice Standardization 0 3 
Other 0 0 
 
 
 
Table 6: Obstacles to Collaborative Participation among New Site Participants 
Obstacles to Participation (New Site Interviewees, n=4) # Times Mentioned 
Time 3 
Need for infrastructure 1 
Provider support for quality improvement 1 
Budget 1 
Lack of personnel 1 
Lack of understanding about what QI is 1 
Data collection difficulties 1 
Resources 1 
 
Table 7: Obstacles to Collaborative Participation among Existing Site Participants 
Obstacles of Activity Implementation (Existing Site Interviewees, n=12) # Times Mentioned 
Time 8 
Provider support for quality improvement 7 
Lack of personnel 5 
Transition to EMR 3 
Taking on too much initially/getting in over our heads 3 
Coordinating schedules 1 
Patient/family buy-in 1 
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Table 8: ICN Activities & Descriptions 
ICN Activities Description 
Population management* An interactive program of patient tracking that allows providers to 
examine care provided to each site’s IBD population across various 
multiple categories, such as disease severity, nutritional status, and 
treatment with selected medications 
Pre-visit planning* Process to identify upcoming patient visits and to plan those visits 
before the patient arrives 
Standardized clinic template Standardized clinic flow sheets that allow the physician to 
accomplish a set of goals at a clinic visit 
Nutrition and growth algorithm* An algorithm developed to assess nutrition and growth status at 
each patient visit and improve the management of patients with 
unsatisfactory results.  
IBD Clinic Implementation of a weekly, bi-weekly, or monthly clinic in which 
only patients with IBD are seen 
Multidisciplinary team meeting Team meetings made up of providers from various disciplines to 
discuss IBD patients. Often includes a physician, nurse practitioner, 
nurse, dietitian, and others. 
PDSA cycles Small tests of change particular to each site based on the Plan-Do-
Study-Act model 
Self-management* Tools in the form of workbooks, seminars, CDs or DVDs provided to 
patients and parents to increase their knowledge of IBD and 
encourage greater disease management and medication adherence. 
Model IBD Care Guideline* Guideline developed to standardize diagnosis, disease monitoring, 
and treatment based on evidence and expert consensus 
*Crandall, Kappelman, Colletti et al. In Press. 
 
Table 9: Obstacles Mentioned by ICN Activity 
Obstacles per 
ICN Activity 
Population 
Management 
Report 
Pre-visit 
Planning 
IBD 
Clinic 
Team 
Meetings 
Standardized 
Clinic 
Template 
ICN Data 
Collection 
Nutrition 
Growth 
Algorithm 
Time 4 3 1 2 0 1 0 
Provider buy-in 3 5 1 1 0 1 0 
Personnel  
issues 
3 3 1 0 1 0 0 
Transition to 
EMR 
1 0 0 0 1 1 1 
Logistics/ Clinic 
Restructuring 
1 1 4 0 0 0 0 
 
 20 
 
 
Appendix 1: Further Background on Quality Improvement Collaboratives 
 
Origin of Quality Improvement Collaboratives 
 Promotion of quality assurance in the health care field originated long before the IOM 
reports To Err is Human37  and Crossing the Quality Chasm.14  In 1989, Berwick proposed the 
adoption of The Theory of Continuous Improvement in the field of health care.38  However, for 
years few practitioners took quality improvement seriously because, as Kilo explains, promoters 
of quality assurance focused on cost control, did not know how to motivate physicians, had 
unrealistic expectations of health outcomes, and poorly understood the science of 
improvement.19   
Nonetheless, Berwick‟s goals for improvement in health care39  were the basis for the 
development of the Institute of Healthcare Improvement‟s (IHI) Breakthrough Series (BTS) 
collaborative model in 1998, which aimed to achieve “unprecedented levels of improved 
performance in participating organizations in less than 1 year by bringing providers together to 
understand and drive improvement within a specific topic area” (p. 2).19  The IHI developed the 
collaborative model based on the following principles: 
1. A sustained gap exists between knowledge and practice in health care; 
2. Broad variation in practice is pervasive; 
3. Examples of improved practices and outcomes exist, but they need to be described 
and disseminated to other organizations; 
4. Collaboration between professionals working toward clear aims enables 
improvement; 
5. Health care outcomes are the results of processes; and 
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6. Understanding the science of rapid cycle improvement can accelerate demonstrable 
improvement.19  
The IHI BTS collaborative model offered a framework adaptable for many types of 
diseases, provider networks, and health organizations. Wilson, Berwick, and Clearly 40  
summarized the steps in the BTS Collaborative Model, which are presented in Figure A-1. The 
success or failure of collaborative is dependent on team member interactions, which take place 
during “learning sessions.” Operating under a Plan-Do-Study-Act model, team members learn 
improvement techniques, exchange ideas and advice, and generate enthusiasm and 
commitment to achieving a common goal”20  Learning sessions commonly involve specific 
instruction on improving selected aspects of care, developing, sharing, and refining data 
collection and tracking modalities, and reporting results or recent changes at each site.41   After 
each learning session, team members return to their practice or organization to apply new 
knowledge and evaluate new outcome measures.19  In between learning sessions, access to a 
listserv41  or extranet is common, as are monthly conference calls.  Some collaboratives also 
develop and utilize state- and region-based support, offering technical assistance to 
participating health centers.42  Figure A-2 illustrates the basic framework of the BTS model. 
Figure A-1. Steps of the IHI Breakthrough Series Collaborative Model 
Steps in the Breakthrough Series Collaborative Model 
1. Sponsoring organization identifies topics where a significant gap exists between best and typical 
practice. 
2. The Institute for Healthcare Improvement (IHI) then assembles an expert panel. 
3. Expert panel prepares a package of ideas for closing the gap. 
4. IHI recruits participating teams to be part of the collaborative. 
5. Participants engage in prework: forming a local improvement team, develop goals and measurements, 
and characterize current practice. 
6. During a collaborative‟s life, usually 6-12 months, teams from participating organizations attend three 
learning sessions in which they learn about ideas for better practice and improvement methods that 
they implement between sessions. 
7. Between learning sessions, teams share experiences and maintain contact through such mechanisms 
as conference calls and internet email listservs while submitting progress reports. 
8. The lessons learned are spread through a national meeting (congress) and reports. 
Source: Wilson T, Berwick DM, Cleary P. What do collaborative improvement projects do? experience 
from seven countries. Joint Commission Journal on Quality and Patient Safety. 2004;30(Supplement 
1):25-33. 
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Figure A-2. IHI Collaborative Framework 
 
LS: Learning session 
 
Source: Kilo CM. A framework for collaborative improvement: Lessons from the institute for healthcare 
improvement's breakthrough series. Quality Management in Healthcare. 1998;6(4):1.  
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Appendix 2: Limited Systematic Review of Quality Improvement Collaboratives 
Introduction 
 Investigators have identified deficiencies in the safety and quality of health care provided 
in the U.S. 14, 37  Among recommendations proposed by the Institute of Medicine‟s Crossing the 
Quality Chasm is one promoting collaboration among clinicians, institutions, and patients 
through shared knowledge, free flow of information, evidence based decision making, and 
transparency of health system processes.14  In addition, financial rewards linked with clinical 
outcomes further incentivize adoption of quality improvement methods.43  Quality improvement 
collaboratives (QICs) represent one systems-based approach to improve health care quality and 
patient outcomes.  
 The purpose of this review is to provide an overview of the literature surrounding QICs, 
to classify the types of analyses performed on chronic disease QICs, and to appraise the quality 
of literature examining their effectiveness.  First, we will briefly describe the evidence base for 
QICs. Then, we will report the methods, results, and discussion of a systematic review of 
studies examining collaboratives specifically focusing on chronic disease. Finally, we will outline 
suggestions for future research.  
Evaluation of the Evidence Base Surrounding QICs 
Since the inception of IHI‟s BTS collaborative model, various health care systems, 
organizations, and groups of providers have adopted versions of collaboratives to fit their needs. 
Improving surgical and critical care outcomes in hospitals were among the first targets of 
collaboratives. Early quality improvement collaboratives included the Northern New England 
Cardiovascular Disease Study Group,21  the US Veterans‟ Affairs National Surgical Quality 
Improvement Program,44  and the Vermont Oxford Network,45  which aimed to improve hospital 
mortality associated with coronary artery bypass graft surgery, morbidity and mortality rates 
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after major surgery, and quality of care for very low birth weight infants neonatology survival 
rates, respectively.  
Utilization of collaboratives quickly expanded from hospital-based outcomes to 
outpatient-based diseases and illnesses. As of 2003, the IHI had conducted collaboratives with 
over 700 teams working on 23 clinical conditions.41  In addition, the U.S. Health Resources and 
Services Administration46  and the Veterans Health Administration47  adopted the QIC method. 
Moreover, adoption of collaboratives expanded beyond the Unites States. Australia, France, the 
Netherlands, Norway, Sweden, and the United Kingdom‟s National Health Services have 
developed and implemented variations of collaborative programs.40   
Numerous studies document the effectiveness of particular quality improvement 
collaboratives (QICs). Investigators credit the implementation of QICs for reduced inpatient 
mortality rates associated with coronary artery bypass graft procedures,21  decreased neonatal 
infection rates,48  decreased c-section rates,49  less costly prescriptive practices,50  improved 
patient safety,50  decreased emergency department waiting times,51  and improved management 
of patients with chronic disease.50 52  Such studies support the use of quality improvement 
collaboratives as a viable method for identifying and implementing best practices.  
Few studies in the literature conclude that QICs are ineffective, but Landon and 
colleagues41  offer one example. They performed a prospective matched pre- and post-
interventions study of almost 10,000 HIV-infected patients and found that a multi-institutional 
quality improvement collaborative did not significantly affect the quality of care.41  
Other studies sought to identify and explain components of successful collaboratives, 
which often take the form of informant interviews. Ayers and colleagues53  used open-ended 
questions of 18 key informants involved in successful data-driven quality improvement learning 
collaboratives in the U.S. and Europe. They identified the following patterns:  cultivating trust, 
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attendance to the human dimension, nonlinear development, attendance to organizational 
culture, integrated philosophy of quality improvement, and a focus on process and outcome 
measurement to drive change.53  Meanwhile, Wilson and colleagues40  performed semi-
structured interviews with 15 leaders of collaboratives to ascertain the features of effective 
collaboratives; they identified the following seven critical determinants: sponsorship, topic, ideas 
for improvements, participants, senior leadership support, preliminary work and learning, and 
strategies for learning about and making improvements.40  However, the internal validity of these 
studies is questionable because of variation in collaborative frameworks, which targeted a 
diverse set of medical outcomes and settings, ranging from ambulatory care to critical care 
units. Similar inconsistencies are rampant in the QIC literature. 
 
Methods 
 We conducted a MEDLINE search to search for literature written about chronic disease 
QICs published before January 2010. The search algorithm appears in Figure A-3. We used the 
following MeSH terms: “quality” AND (“cooperative behavior” OR “cooperative” AND “behavior” 
OR “collaborative”) AND “improvement.” Our 2-person team reviewed the titles and abstracts of 
articles appearing before January 9, 2010. To obtain additional articles not recovered in our 
MEDLINE search, we hand-searched references of sentinel articles. 
We included studies that were written in English, took place in the U.S., examined 
collaboratives targeted at one or more chronic diseases, and met the definition of collaborative.  
In an ad hoc manner we defined a quality improvement collaborative (QIC) as “a voluntary 
network of health care providers in more than one health care system, who agree to share data 
and information on processes of care for the purpose of improving the quality of care and 
patient outcomes.”  This definition was based on a pilot search and review, which identified 
important components of these interventions as including identification of variations in care or 
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deviations from published guidelines, defined, measurable outcomes, a willingness to pursue 
active information sharing, and collection of data with the intent to study the effectiveness of the 
intervention.  These variables, and others, were also identified in a systematic review of 
collaboratives by Schouten et al, which helped add a measure of validity to our original search 
goals and inclusion criteria, for quality improvement collaboratives.54    
We excluded articles if the collaboratives took place in the settings of improvement in 
emergency departments, intensive care units, and primary care practices not focusing on a 
particular chronic disease. We also excluded articles written about collaboratives focused on 
organ donation, general preventive measures, medical imaging, surgical interventions, and 
palliative care.  
From abstracts and full-texts of the articles meeting inclusion and exclusion criteria, we 
extracted the following information: the authors and year of the publication, the disease or 
medical specialty (i.e. pediatric cardiology, psychiatry, etc.) addressed in the collaborative, the 
setting of the collaborative participants, and the type of analysis performed by authors. We then 
classified the types of analyses into the following three broader categories: process and 
methods, sustainability, and effectiveness. Process and methods included articles written about 
the need, development, and implementation of quality improvement collaboratives. The 
category of sustainability included articles that described or identified internal or external 
resources necessary to sustain the effects of a collaborative.  Among these, we also recorded if 
authors addressed the importance of team work or informatics as necessary components of the 
collaborative investigated. Finally, the category of effectiveness included articles that evaluated 
the effectiveness of collaboratives on patient outcomes.   
Next, we appraised the quality of studies measuring the effectiveness of QICs. We 
reviewed the articles classified in the category of effectiveness for studies reporting patient-
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oriented outcomes. We excluded studies evaluating effective components of a collaborative, i.e. 
teamwork or information technology, and studies examining exclusively non-disease specific 
outcomes. From the studies meeting these inclusion and exclusion criteria, we extracted the 
following information: the disease or medical condition addressed by the collaborative, a brief 
description of the study, the study design, the participants in the analysis, the source of 
assessment, the outcomes assessed, the methodological status, the duration of follow-up, and 
the findings. For each study, we appraised the internal validity, external validity, and the clinical 
utility of the measured outcomes.   
 
Results 
 The MEDLINE search algorithm produced a total of 626 articles, but only 51 met 
inclusion criteria. A hand-search of pertinent literature yielded five additional articles. Table A-1: 
Literature for Systematic Review details the classification of the 56 articles. Nineteen fell into the 
category of process/methods, 15 in sustainability, and 22 in effectiveness.  
 
Categories of Literature 
Process/methods articles focused principally on the formation and evolution of the 
development of collaboratives. If collaboratives were new to a particular medical field, such as 
pediatric cardiology or pediatric gastroenterology, investigators published articles outlining the 
need for a QIC and often detailed an adapted model to suit the goals and needs of the field. 
Other process/methods articles focused on the implementation of a collaborative or evaluated 
the implementation by measuring clinic or physician practices. 
 28 
 
Articles classified under the categories of sustainability and effectiveness reported 
various outcomes about collaboratives that had been in operation for at least one year. In 
general, sustainability articles reported the necessary components to sustain the quality 
improvement practices initiated because of a collaborative. Some investigators addressed 
sustainability of a collaborative itself, while others focused on specific components of the QIC. 
To evaluate which components of a QIC were effective, investigators often conducted 
qualitative methods, such as interviews with key informants. Six sustainability studies55-60 61  
mention information technology as a necessary component, while 455-58  of these specifically 
evaluate a particular type of technology utilized in the collaborative. Three sustainability 
studies60-62  cited an element of teamwork as an effective QIC component. One study evaluates 
the cost-effectiveness of implementation of a QIC.  
Investigators evaluated a variety of outcomes of collaboratives in studies classified in the 
category of effectiveness. The outcomes examined are as diverse as the goals for initiation of 
collaboratives. For instance, some QICs aim to reduce disparities among diabetic patients, while 
others evaluate physician practices and patient-outcomes.  
Unsurprisingly, most collaboratives address common health conditions, such as heart 
failure, diabetes mellitus, asthma, and depression. QICs focused on HIV and stroke were also 
common. Unique medical topics included urology and COPD. Pediatric illnesses were also 
represented in the chronic disease QIC literature. Common pediatric conditions or topics 
addressed included asthma, inflammatory bowel disease, development disorders, cardiology, 
and rheumatology. 
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Critical Appraisal 
 A summary of the systematic review of QIC effectiveness studies is provided in Table A-
2: Critical Appraisal. Overall, 13 manuscripts met the inclusion criteria for the systematic review 
of the effectiveness of QICs. 41, 42, 63-67, 67-73   Of these, only 3 studies involved a randomized 
component in their study design.  Five included studies 41, 42, 63, 64, 70  used a comparison group 
study design, with selected intervention sites and control sites, not unlike a case-control design.  
Three studies66, 67, 70, 72 used quasi-experimental before-and-after designs, one73  used a cross-
sectional analysis of a state‟s health plans, and two studies65, 68  were uncontrolled cross-
sectional analyses of a single site participating in a collaborative intervention.73   
 
Randomized Studies 
Two of the studies featuring a randomized component69, 71 used a cluster randomized 
controlled trial design, randomizing at the practice level to assess the intervention. One study67  
was designed primarily as a quasi-experimental before-and-after design, but randomized 
selected centers to either standard or high-intensity collaborative interventions, the latter 
involving four additional learning sessions and provider training. On the whole, none of these 
randomized trials or arms found that collaborative quality improvement interventions led to 
improved outcomes.67, 69, 71  One study randomized forty-three practices in greater Detroit and 
greater Boston to participation in a learning collaborative based on Breakthrough Series 
methodology or standard care.69  For children with asthma, Homer et al. found no significant 
improvements in asthma process-of-care outcomes, clinical outcomes, or utilization outcomes 
for individuals randomized to the intervention group.69  Another randomized study,71 undertaken 
by Philbin et al., randomized ten hospitals in the upstate New York.  Intervention hospitals 
received an intensive, multifaceted quality improvement intervention consisting of educational 
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sessions, critical pathways, and lectures. The New York research team found no significant 
improvements in process-of-care markers or clinical outcomes among intervention sites 
compared to controls.  However, a slight, non-significant reduction in hospital length-of-stay was 
observed among intervention hospitals. The third and final study with a randomized component 
that fit our inclusion criteria was a study of a diabetes quality improvement collaborative, 
undertaken by Chin et al.67  Embedded in a longitudinal study looking at the effect of a 
collaborative quality improvement intervention for, sites treating patients with Type 2 diabetes 
were randomized to either a high-intensity and standard protocol after 1-2 years of participation. 
For ACE inhibitor and aspirin use, Chin et al. found slightly higher documented rates of 
compliance.67  However, for many other intermediate incomes, and for clinical outcomes 
measures, there was no significant effect of the higher-intensity intervention.67  For several of 
the intermediate outcomes, including HbA1c levels and systolic blood pressure measurements, 
control sites out-performed sites that participated in the high-intensity intervention. 
 
Observational Studies 
The majority of the studies included in our review were observational studies, employing 
several different designs. The preponderance of observational study designs among our 
included studies mirrors the predominance of non intervention-based, observational studies in 
the literature on collaboratives.  Four studies41, 42, 63, 64 that met inclusion criteria for our report 
were observational studies molded as case-control studies at the practice level. These studies, 
offering fewer statistical limitations and theoretically fewer potential confounders and biases in 
their study design than simple before-and-after studies, represented the most common type of 
study included in our report.  Asch et al. studied the effects of a BTS collaborative on heart 
failure outcomes and found a significant positive effect of collaboratives on counseling and 
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education outcomes, as well as positive effects on rates of ACE inhibitor and lipid-lowering 
therapy for heart failure patients.  However, Asch et al. found no improvement in readmission 
rates for patients at participating sites.63   Landon et al., in 2004, published results from a similar 
assessment of a BTS collaborative, this time concerning HIV treatment and quality.  Comparing 
44 intervention sites to 25 control clinics primarily on the basis of control of viral load and 
prevention of opportunistic infections, investigators found no significant differences in outcomes 
between the two groups.  Although the end result was a lack of significance, the proportion of 
patients with viral load controlled increased twice as much in the intervention group compared to 
the control group; these figures were 11.0% improvement (40.7 to 51.7) and 5.4% improvement 
(44.1 to 49.5), respectively.41  
Despite mediocre results in the EQHIV study, another Landon-led research team 
assessed the effects of collaboratives on management and outcomes of asthma, diabetes, and 
hypertension.42  Interestingly, for these common chronic diseases, Landon et al. found that 
collaborative participation was associated with improvements in screening, prevention, and 
disease monitoring, for patients with asthma and diabetes.42 Similar improvements were not 
seen with hypertension, however.  For diabetes and hypertension, there was virtually no effect 
of collaboratives on clinical outcomes.  In contrast to these results, Baker et al. found that 
participation in a collaborative for heart failure reported much higher quality of life, satisfaction 
with medical care, and knowledge of their condition.64  Most importantly, patients in the 
intervention group utilized less care, in terms of hospitalizations, than those in the control 
group.64  Despite selection concerns in this study, the utilization outcomes data shows that 
meaningful improvement likely did occur.  The final study comparing “intervention” sites to 
selected control sites assessed the effects of a quality improvement collaborative on quality of 
care and outcomes for childhood asthma. 70  Comparing nine intervention sites with four control 
sites, Mangione-Smith et al. found significant improvements in process-of-care measures and 
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patient self-management skills.  However, small differences in health utilization outcomes 
between the two groups were not statistically significant, echoing the non-significant findings of 
this type in several other studies.42, 72     
Of the remaining studies that fit our inclusion criteria, three employed a before-and-after 
design, one analyzed variations in care from the perspective of a state health plan, and two 
studies were uncontrolled studies, reporting results and experiences related to a single site‟s 
participation in a collaborative.  Two of the before-after studies targeted Health Disparities 
Collaboratives (HDCs).  Both of these 66, 67  studied the effect of collaborative interventions on 
diabetes care, using a collaborative structure that emphasized involvement of community health 
centers, combining semi-structured interview data with surveys and reviews of medical records.  
In these studies, investigators found significant improvements across the board, from process-
of-care measures such as HbA1c checks, foot and eye exam referrals, and lipid assessments, 
as well as HbA1c control, an intermediate outcome that for diabetes surves as a monitor for 
disease control.  Between the two studies the improvement in HbA1c ranged from 0.2%66 to 
0.45%,67 although this difference was not significant in either case.  The third study with a 
before-after study design72  actually included control sites for comparison, but the control sites 
had dramatic differences in location and payor mix compared to intervention sites, so for the 
purposes of this analysis the study was treated as a time series analysis.  Schonlau et al. found 
several significant differences between intervention clinics and control clinics, including several 
satisfaction and self-management indicators.72  With only 9 included centers, however, the 
number of utilization outcomes or events (e.g., emergency room visits) was very small, 
preventing investigators or readers from reaching meaningful conclusions from the results. For 
example, during the 13 month period of the study, in the intervention group there were two 
emergency visits by patients during the study (according to survey data), compared to a single 
ED visit among control patients.72  
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One study73  that met our inclusion criteria found positive gains attributed to a statewide 
collaborative for Diabetes quality improvement.  Reported from the perspective of Wisconsin-
based HMO health plans, Siomos et al. found incremental improvements in LDL and HbA1c 
monitoring, nephropathy screening, and eye exam referrals.  However, absent in this study were 
descriptions of which HMO plans were included for each year of analysis as it varied according 
to year, and was not explicitly tracked.  Nor was there included information on selection of sites, 
clear presentation of results, or analysis of findings.  The final two studies that met our search 
criteria65, 68  had similar validity questions, stemming from incomplete and haphazard reporting of 
results, no arrangements or discussion of secular trends, and lack of demographic information 
on included patients or sites.  In addition, Benedetti et al. and Fox et al. presented select 
information on only one participating center, which drastically limits the validity of these studies.   
With no substantive discussion of secular trends, the primary purpose of these studies was 
informative.  From an appraisal standpoint, however, these two studies do little to prove that 
quality improvement collaboratives have a positive, meaningful effect on quality of care and 
outcomes. 
 
Discussion 
 The literature on chronic disease QICs is appropriately diverse to coincide with the 
variety of chronic diseases and conditions and the range of goals QICs seek to address. For 
instance, the heterogeneity of HIV patients seen at outpatient care facilities may require 
completely different management strategies from visit to visit. Thus, an HIV collaborative may 
be less fitted to a rigorously systematic, QIC methodology.  
The three categories of process/methods, effectiveness, and sustainability represent the 
natural evolution of QIC literature. Investigators will continue to report adapted QIC processes 
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and methods for different conditions. Next, collaborative participants must measure patient 
outcomes and determine what components of the QIC contribute to those outcomes. Finally, 
identifying and developing methods to sustain quality improvement is crucial. The literature thus 
far indicates chronic disease QICs are at an early evolutionary stage. 
In particular, investigators need to measure consistent patient outcomes to strengthen 
the evidence of effectiveness of chronic disease QICs. Doing so requires reliable and valid 
quantitative medical research designs. However, the transition to evaluation of effective QIC 
components and how to sustain them likely requires qualitative research methods, which may 
be a challenge for clinical investigators unfamiliar with such methods. 
An appraisal of the chronic disease QIC effectiveness literature reflects poor internal 
validity. Randomized controlled trials have the greatest potential to maximize internal validity, 
but they are rare in the literature. We did not find consistent, corroborated evidence proving the 
effectiveness of collaboratives.  
There are several limitations of these studies that both weaken the strength of the 
results and highlight the difficulties inherent in effectiveness research on quality improvement 
collaboratives.  Unfortunately, conducting assessments of practice-based interventions is quite 
difficult, especially for the purposes of directing public policy or solidifying a research base that 
meets commonly referenced reporting standards.  Utilization of non-randomized studies, up to 
this point unofficially, as the primary method for proving the effect of collaboratives on improving 
the quality of care is fraught with hazard.23   Put simply, the greater the concern about the 
methodological quality of some of these studies, the less we know that their results are valid.  
For example, when only a small fraction of sites participating in a collaborative volunteered to be 
studied as intervention sites, there were many ways for that sample to be a non-representative 
one.  Leaders at underperforming sites participating in a collaborative, especially with data 
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collection aids, likely were aware of their sites‟ relative poor performance, and may not have 
volunteered for a study because of their own inherent belief that collaboratives are beneficial.  
Randomization affords the investigator the opportunity to account for both known and unknown 
confounders, and with special relevance for collaborative-based interventions, has the potential 
to eliminate biases associated with secular trends.  Still, RCTs are not immune to biases, and 
what follows is a discussion of limitations associated with the randomized studies that analyzed 
the effectiveness of collaboratives.   
 In the study by Homer et al.,69 a much higher percentage of patients enrolled in control 
sites were on Medicaid.  In addition, as reported by the study authors, the risk of contamination 
in the study was high. This arises from the fact that although 43 sites were randomized at the 
start of the study, representing the largest sample of clinics included in our review, all forty-three 
practices were located in one of two geographic areas.  In one of the studied regions (Detroit, 
MI), all of the participating sites, regardless of control or intervention status, were under the 
same ownership.  An unknown dilution factor could have assimilated the medical practice of 
intervention and control sites that happened to employ the same physicians, but the effect this 
had is uncertain.  In addition, there is no way to ascertain the level of participation or 
commitment at each site, given that sites were randomized, and some sites with limited 
investment in the project may have diminished the magnitude of effect at certain sites.   
Another randomized study, undertaken by Philbin et al.,71 randomized 10 practices to 
either an intensive quality improvement intervention or standard care, for patients with heart 
failure.  This study was exposed to fewer potential biases than the earlier study, primarily due to 
minimal contamination concerns, but had limitations of its own.  First, blinding was not 
maintained during the study.  In addition, as is the case with the other randomized studies, it is 
difficult to know what effect any secular trends, among the control sites, may have had.  Further, 
as with other randomized study designs analyzing the effect of practice-level interventions, it is 
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very difficult to ascertain the intent or strength commitment of participating clinics and their 
leaders and practitioners.  Leadership is an oft-mentioned component of successful quality 
improvement and collaborative interventions.47, 74  Additionally, although Philbin et al. made 
heart failure the focus of their study, the primary evaluations were carried out from the 
perspective of acute inpatient diagnosis and treatment, rather than chronic outpatient care.   
The final study that included a randomized component in the study design was 
conducted by Chin et al.67  The randomization to either standard-intensity intervention (with no 
additional learning sessions) or the high-intensity intervention (attendance at 4 additional 
learning sessions) did not give any significant differences between groups.  However, there are 
several reasons why a true benefit to collaborative interventions might have been missed here.  
First, even though the study used randomization, it is vital to note that randomization occurred 
1-2 years into the study, at which time all included sites had been participating in the 
longitudinal, observational study, attending collaborative learning sessions, and engaging in 
quality improvement measures.67  Thus, a majority of the attainable improvement may have 
already been reached by the time of randomization. In addition, as is the case with the vast 
majority of studies on collaborative interventions, documentation variation plays as substantial 
role in the perceived effectiveness of collaboratives, in many of these study designs.  In this 
particular study, the high-intensity intervention was associated with less documentation of 
diabetes education and exercise counseling. However, additional attention to medication 
adjustments and communication may have left less time for counseling in a short clinic visit. Or, 
physicians may have continued with counseling but spent less time documenting so in medical 
charts. The uncertainty with documentation issues like these clouds a final judgment of 
effectiveness of the high-intensity intervention.   
The longitudinal study published by Chin et al. in 200466  as well as the longitudinal study 
(with the embedded randomized component) published in 200767  both are burdened with a 
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serious validity concern that affects any before-after study of this type.  Unlike the more 
sophisticated interrupted time series design75  that employ time series regression models to 
reduce unwanted bias in their design, before-after or time-series designs have few defenses 
against the risks of secular trends.  In a health care environment with increasing awareness of 
quality of care and quality improvement, especially since the release of the IOM reports, the 
potential effects of secular trends are substantial.  During observational studies like these, 
unknown and unstudied events can occur at any subset of participating sites, drastically 
weakening the ability of readers to make causal inferences about their results.75  Internal validity 
can easily be compromised, especially if studies essentially conduct two-sample t-tests on pre-
intervention points and post-intervention points. Doing so gives inaccurate effect sizes if pre-
intervention trends are present.75     
Certainly, not all observational should be judged equally. Achieving improved quality of 
care for HIV patients, as discussed in the EQHIV study,41 in many ways represents a more 
difficult challenge than doing so for patients with chronic cardiovascular disorders, such as 
hypertension or diabetes. At any particular site in the EQUIV study, especially in a non-
randomized environment, variation in follow-up, medication adherence, and insurance status, 
could conceivably have a larger effect on care outcomes than the actual care received in the 
clinic. Adherence to anti-retroviral medications, for example, is directly correlated to HIV viral 
load, although adherence could be a confounding variable in a non-randomized study. In 
addition, socio-economic and demographic characteristics of the patient population, clinic 
organizational cultures, and financial and regulatory issues make the task considerably more 
complex.76   Landon et al. attempted to account for known confounders by matching intervention 
sites to control sites according to several criteria.  Rigorous observational study designs like the 
EQUIV study can be useful, although currently there is no method for assessing the role of 
leadership at participating sites.  Although it is potentially just as problematic in randomized 
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studies, since sites with strong leadership could all be randomized to control sites, the effect of 
a quality improvement “champion” or leader at sites participating in a collaborative is universally 
understood and valued by those with collaborative experience.19, 74  Sites without motivated 
leaders may consistently underachieve compared to centers with strong leadership.  
Unfortunately leadership is difficult to assess in these studies.   
Another problematic issue when analyzing and interpreting the literature on the 
effectiveness of collaboratives is the almost universal reliance on medical records for data 
collection.  As discussed previously concerning the randomized intervention undertaken by Chin 
et al, this problem drastically undermines the ability to draw conclusions from uncontrolled 
studies,65, 68  in which simply increasing documentation in a practice or practices can give the 
impression that large improvements in care have occurred.  But even for more sophisticated 
studies, determination of statistical significance from medical records alone is troubling.  If, for 
example, a learning session emphasizes preventive counseling and lifestyle changes for heart 
failure, does finding a higher percentage of patients with “dietary counseling” in their chart 
indicate quality improvement?  For evaluation of prevention and screening measures, an 
undocumented test or discussion is one that for the purposes of analysis did not occur.  Further, 
in practice-based intervention studies where blinding is seldom performed, an increased 
emphasis on documentation may falsely create the sense of improvement when the only 
improvement has been documentation itself.64   This apparent effect may be embellished further 
by investigators who, although they have the best of intentions, are invested in collaborative 
methods and intrinsically believe in their value.  Although not a central point in published 
guidelines for reporting observational studies,77 blinded, dual review is a vital component of 
systematic reviews and dual review could potentially be used to increase the validity of these 
types of studies.  Such a measure would not eliminate potential biases that can arise from 
review of medical records, however.   
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Still, an important distinction about medical record abstraction should be made here, 
because some endpoints can be reliably taken from medical records. One of the most important 
uses of medical records is making a determination of definite clinical outcomes, such as MI, 
stroke, death, or other conditions that are easily defined and reliably documented.  However, of 
the 14 studies we evaluated that analyzed the effect of collaboratives on chronic disease care, 
only 6 (or 43%) even collected data on clinical outcomes. Data tables in these articles are filled 
with satisfaction measures, quality of life indices, and process-of-care targets, some of which 
are linked to improved outcomes. However, higher indicators now do not equal improved 
outcomes in the future.  Whereas there can be disagreement among scales and indices when 
researchers assemble them together to make a clinical judgment, as in a meta-analysis, there is 
no dispute when studies publish hard, easily defined, concrete outcomes. Of course, improving 
quality of care is not limited to keeping patients alive, and true quality includes many of these 
components.  In addition, the current medical record abstraction method for data collection in 
these practice-level interventions is quite useful for some conditions. For instance, heart failure 
is a condition that arguably is quite better suited to medical record abstraction. For heart failure 
patients, unlike patients with other medical conditions, utilization outcomes can be used as a 
proxy measure for disease control. With diabetes mellitus, the pathological processes 
underlying the disease are often undetectable to afflicted patients, and long-term adverse 
events like heart attacks, strokes, and peripheral vascular complications are most commonly 
measured. For heart failure, a poorly controlled patient is a symptomatic one, who will likely 
present to the hospital with more short-term needs. 
 
Future Directions 
 Despite the hope that collaboratives do improve care enough to lead to improvements in 
satisfaction, processes of care, and self-management, the evidence linking these changes to 
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improvements in patient outcomes is somewhat underwhelming.  With these limitations, 
however, come opportunities for improvement, and there are other indications that 
collaboratives may be more successful than the demonstrated evidence currently indicates. For 
instance, many collaboratives are currently ongoing.  Although funding constraints and logistical 
issues have prevented long-term data collection and analysis for the purposes of publication, 
these opportunities will increase the future.   
Although the literature to date contains some methodological flaws, the sense of 
cooperation, information-sharing and camaraderie that these interventions can create, both 
between sites and within sites, is likely already leading to improved care.  In a recent study by 
Bray et al, researchers found that even once a collaborative project with a defined-length of 
operation ended, many of the quality improvement programs, from infrastructure support, 
regular meetings to study patient data, and leadership development, remain in place at 
participating clinics.61    
QICs are likely to become more frequent in pediatrics as the American Academy of 
Pediatrics now requires participation in quality improvement projects.  In the Education in 
Quality Improvement for Pediatric Practice (EQIPP) program, qualified improvement projects 
help distribute practice-wide data on effectiveness and management.78  Enrollment in such a 
program allows one to receive credit that is required under Maintenance-of-Certification 
guidelines for Pediatricians.  Collaboratives may be beneficial to streamline practices, 
implement efficient data management strategies, and improve patient tracking, but they are not 
equally suited to all diseases treated in an outpatient setting.   Investigators and researchers 
must systematically define, through assessments of performance outcomes and medical record 
audits, which disease processes are more amenable to collaborative interventions and which 
are less so. 
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 The gaps remaining in the literature must be addressed by subsequent investigators.  As 
mentioned earlier, current medical management of certain chronic diseases are unclear and 
must be defined.  Such a step requires commitment of regulatory agencies and professional 
medical associations alike.  An effort should be made to increase the number of facilities 
involved in these interventions, to strengthen the ability of statistical techniques to show 
significant conclusions.   In addition, an increased number of included clinics, from various 
geographic, socioeconomic, and organizational styles, must be approached and included.   
Second, key investigators and journal editors must establish standards for research 
design and methods for evaluating collaboratives to ensure reliable, valid, and comparable 
findings, which may facilitate future systematic reviews and meta-analyses.20  Third, sponsoring 
agencies of QICs need to provide more information regarding the teaching and implementation 
of collaboratives.41  The IHI BTS collaborative model provides the most detailed information on 
collaborative start-up; however, many variants exist. Additionally, BTS collaboratives were 
designed to last one year or less and offer little direction for providers once a particular 
collaborative is over.  
Finally, quality improvement remains a complex issue in health care. If inconsistent 
research designs prevent the identification of successful components of QICs, then the 
components necessary to sustain quality improvement following the completion of a 
collaborative is less certain. An evidence base for quality improvement itself must be improved. 
Future research must address concepts regarding the nature of quality problems, quality 
improvement processes, and the types of research needed to elucidate these processes.20   
As the push for improved health care processes and patient outcomes continues, quality 
improvement collaboratives present a popular method to develop best practices, which may 
shape future payment systems.  Collaboration between like-minded physicians can increase 
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camaraderie, facilitate data, speed the adoption of best practices, and most importantly, 
improve care for patients with chronic disease.  However, the research methods to evaluate 
collaborative interventions require a different mindset, and standards different from those 
required of a drug trial or biochemical assay.  As interventions effecting practices, collaboratives 
are tests of teamwork, leadership, and commitment.   With a renewed emphasis on patient care 
and best practices, the true effect of these QI interventions remains to be seen.  Until then, 
collaborative interventions may represent some of the most ambitious efforts to change 
outpatient care delivery for patients with chronic diseases. 
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Table A-1:  Literature for Systematic Review 
Article Year Medical Topic/ Condition Category Setting 
Asch, et al. 2005 Congestive Heart Failure & Diabetes Mellitus Effectiveness 4 IHI BTS participating health care organizations & 4 controls 
Baker, et al. 2005 Heart Failure Effectiveness 
6 health care organizations participating in an IHI BTS 
collaborative 
Ballard DJ et al. 2002 Diabetes Mellitus Effectiveness 
22 primary care practices in a network owned by Baylor Health 
Care System 
Benedetti, et al. 2004 Diabetes Mellitus Effectiveness Sites participating in a Washington state diabetes collaborative 
Bonomi AE et al. 2002 Congestive Heart Failure & Diabetes Mellitus Effectiveness 
108 organizational team from across the US active in 1 of 4 IHI 
QICs 
Chin MH et al. 2007 Diabetes Mellitus Effectiveness 
24 health care centers in the Health Disparities Collaborative for 
2 years 
Chin MH et al. 2004 Diabetes Mellitus Effectiveness 19 Midwest health centers 
Cretin S et al. 2004 Diabetes, CHF, asthma, depression Effectiveness 37 participating organizations, 22 control sites 
Fox J et al. 2006 Acute MI & Heart Failure Effectiveness 5 hospitals in Wichita, KS 
Homer, et al. 2005 Pediatric Asthma Effectiveness 43 clinics in the greater Detroit & Boston areas 
Johnson EA et al. 2005 Diabetes Mellitus Effectiveness 40 primary care practices in 3 rural states 
Katzelnick DJ et al. 2005 Depression Effectiveness 20 ethnically & geographically diverse health care organizations 
Landon BE et al. 2004 HIV Effectiveness 44 intervention clinics & 25 matched control clinics 
Landon, et al. 2007 Diabetes, Asthma, Hypertension Effectiveness Community health clinics in the Health Disparities Collaborative 
Mangione-Smith R et al. 2005 Pediatric asthma Effectiveness 13 primary care clinics 
Meehan TP et al. 2004 Hypertension Effectiveness 17 primary care practices treating Medicare patients 
Otley AR et al. 2006 Pediatric Inflammatory Bowel Disease Effectiveness 18 US & Canadian centers 
Philbin EF et al. 2000 Heart Failure Effectiveness 10 acute care community hospitals in upstate NY 
Schonlau M et al. 2005 Asthma Effectiveness 
6 intervention clinics & 3 matched control sites in an asthma 
collaborative 
Siomos EE et al. 2005 Diabetes Mellitus Effectiveness Managed care plans participating in state diabetes collaborative 
Stoeckle-Roberts S et al. 2006 Stroke Effectiveness 13 Michigan hospitals in a stroke collaborative 
Swanson KA et al. 2007 Depression Effectiveness 
Sample of 11 of 108 community-based health care organizations 
in a national depression collaborative 
Boratgis G et al. 2007 Heart Failure & others Process/Methods 3 collaboratives addressing chronic disease or chronic care 
Bousvaros A et al. 2006 Pediatric Inflammatory Bowel Disease Process/Methods N/A 
Britton LF et al. 2008 Pediatric Cystic Fibrosis Process/Methods 1 center of 14 receiving a CF collaborative grant 
Deprez R et al. 2009 COPD Process/Methods 18 primary care clinics in rural Maine 
Fitzgerald E et al. 2005 Psychiatry Process/Methods NJ state mental health services & psych hospitals 
Jenkins KJ et al. 2008 Pediatric Cardiology Process/Methods Various centers involved in pediatric cardiology collaboratives 
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Kristofco RE & NM 
Lorenzi 2007 Depression Process/Methods 23 ethnically & geographically diverse health care organizations 
Kugler JD et al. 2009 
Pediatric Cardiology-Hypoplastic Left Heart 
Syndrome Process/Methods Members of the Joint Council on Congenital Heart Disease 
LaBresh KA et al. 2006 Stroke Process/Methods Members of a national stroke registry 
Mandel KE et al. 2007 Pediatric Asthma Process/Methods 44 pediatric practices in an asthma improvement collaborative 
McInnes DK et al. 2007 HIV Process/Methods 54 intervention HIV clinics vs. 37 control clinics 
Moeschler JB et al. 2009 
Pediatric Developmental Delay/Intellectual 
Disability Process/Methods 5 clinical genetics practices in Northern New England 
Newton PJ et al. 2006 Heart Failure Process/Methods N/A 
Pearson ML et al. 2005 CHF, DM, depression, asthma Process/Methods 42 organizations in 3 QICs 
Rosenman MB et al. 2006 CHF, DM, asthma Process/Methods State-sponsored collaborative made up of PCPs of Medicaid pts 
Ruperto N et al. 2004 Pediatric rheumatology Process/Methods 2 international networks of pediatric rheumatologists 
Schwamm L et al. 2006 Stroke Process/Methods N/A 
Siegel B et al. 2009 Heart Failure Process/Methods 2 acute care hospitals in a multi-hospital collaborative 
Sostman HD et al. 2005 Various Process/Methods 2 academic medical centers 
Bray P et al. 2009 Chronic Diseases Sustainability 13 primary care sites in NC 
Brownson CA et al. 2007 Diabetes Mellitus Sustainability 20 diverse health care teams across the US in a collaborative 
Cole SA et al. 2006 Depression & Congestive Heart Failure Sustainability 
24 patients in a Northeast large not-for-profit provider health 
system 
Davies E et al. 2005 Various Sustainability 8 medical groups in MN 
Deo S et al. 2009 HIV/AIDS Sustainability Cross-section of Ryan White CARE Act funded clinics 
Desai J et al. 2003 Diabetes Mellitus Sustainability 
Primary care clinics in a large MN managed care organization 
collaborating with the state public health department 
Fremont AM et al. 2006 HIV Sustainability 9 VHA clinics 
Grant RW et al. 2006 Diabetes Sustainability 14 primary care practices in a multi-hospital health care network 
Green CJ et al. 2006 Chronic Disease Management Sustainability 30 community-based physician participants 
Hankinson MT et al. 2006 Urology Sustainability 5 network facilities of the NJ VHA 
Huang ES, et al. 2007 Diabetes Mellitus Sustainability 
17 Midwestern health care clinics in the Health Disparities 
Collaborative 
Kilbourne AM et al. 2008 Mood Disorders Sustainability Mental health care facility in a VA-academic partnership 
LaBresh KA et al. 2004 Coronary Artery Disease Sustainability 24 MA hospitals 
Meyer B et al. 2002 Depression Sustainability Psychology clinics at Louisiana State University 
Nease DE Jr. et al. 2008 Depression Sustainability 26 primary care clinics in a collaborative 
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Table A-2.   Critical Appraisal 
Study 
Topic or 
Condition Study Description Study Design 
Participants in 
Analysis 
Source of 
Assessment 
Asch, et al. (2005) 
Congestive Heart 
Failure 
Study of 4 sites involved with 
BTS collaborative for chronic 
heart failure 
Observational; 
comparison cross-
sectional study   
4 IHI BTS 
organizations, with 4 
controls 
Medical records of 
patients at both 
intervention and 
control centers. 
Baker, et al. (2005) Heart Failure 
Study of 6 organizations 
participating in BTS quality 
improvement collaborative 
Observational; 
comparison cross-
sectional study  
Patients at participating 
centers, n = 781 
Telephone 
interviews of  
patients 
Benedetti, et al. 
(2004) Diabetes Mellitus 
Discussion and Results from 
a site participating in the 
Washington State Diabetes 
Collaborative 
Observational; cross-
sectional study  
Patients at a 
participating center. Medical records 
Chin, et al. (2004) Diabetes Mellitus 
Evaluation of 19-member 
Diabetes Health Disparities 
Collaborative 
Observational; 
Before-and-after 
study  
Patients at participating 
centers (n= 969); QIC 
participants via surveys 
and interviews (n=79). 
Medical records; 
surveys; qualitative 
interviews 
Chin, et al. (2007) Diabetes Mellitus 
Evaluation of effectiveness 
of a Health Disparities 
Collaborative 
Before-after 
comparison of 
participating centers 
with embedded 
randomized 
component  
Patients at participating 
centers in 1998, 2000, 
and 2002 (n = 2364, 
2417, and 2212, 
respectively) Medical records 
Fox, et al. (2006)  
Acute MI or Heart 
failure 
Associations between 
collaborative participation 
and improved quality of care 
Cross-sectional 
study, (18 months) 
Clinics participating in 
QIC (n = 5). 
Self-report of 
compliance with pre-
determined 
guidelines. 
Homer, et al. 
(2005) 
Childhood 
asthma 
Analyzing the effect of 
practice-level interventions 
on Pediatric asthma care. 
Clustered 
randomized 
controlled trial 
Clinics in greater 
Detroit and Greater 
Boston areas (n = 43) 
Interviews of 
parents, via 
telephone. 
Landon, et al. 
(2007) 
General Medical 
Care 
Evaluation of 138 Health 
Disparities Collaborative 
participants 
Case-control design, 
with matched internal 
and external controls 
Community Health 
Centers 
Randomly selected 
patient records. 
Landon, et al. 
(2004) 
Patients with HIV 
infection 
Study of 62 of eligible 171 
sites participating in CARE 
Act collaborative 
Case-control design, 
using intervention 
sites and matched 
controls 
Different types of 
medical centers 
delivering HIV care 
(n=62 intervention 
sites). 
Self-report of 
participating clinics 
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Mangione-Smith, 
et al. (2005) 
Childhood 
asthma 
Sites participating in a BTS 
collaborative for pediatric 
asthma care. 
Quasi-experimental 
before-and-after 
design. 
Patients at participating 
and selected control 
centers Medical records 
Schonlau, et al. 
(2005) 
Childhood 
asthma 
Sites participating in BTS 
collaborative for asthma 
care. 
Quasi-experimental 
before-and-after 
design 
Patients at participating 
and selected control 
centers 
Medical records and 
surveys of patients. 
Philbin, et al. 
(2000) Heart Failure 
Study of 10 hospitals in 
upstate New York 
Randomized 
practice-
intervention study; 
6 months 
Patients at participating 
and selected control 
centers 
Medical records and 
telephone interviews 
Siomos, et al. 
(2005) Diabetes Mellitus 
State Health Plans, 
participating in a Wisconsin 
Collaborative Project 
Observational; Cross-
sectional analysis of 
medical records 
Patients at participating 
plans Medical records  
 
Table A-2.   Critical Appraisal, cont. 
Study Outcomes Methodological Status 
Duration 
of Follow-
Up Findings 
Internal 
Validity 
External 
Validity 
Clinically 
Significant 
Outcomes 
Asch, et al. 
(2005) 
23 quality 
indicators 
developed for 
CHF 
Baseline measurements (presented).  
Control sites (yes - minimal discussion 
of where control sites came from).  
Standardized outcomes across different 
sites.  Protection from bias (selection 
issues most prominent).  Protection 
from secular changes (NS). 12 months 
(+) effects of 
counseling, 
education 
interventions Fair Fair No 
Baker, et al. 
(2005) 
Multiple patient-
centered 
outcomes, 
including 
symptom 
control, self-
management, 
counseling. 
Baseline measurements (done).  
Control sites (yes).  Characterization of 
selected sites (done).  Standardization 
of outcomes (NS).  Protection from bias 
(retrospective, interview-based 
measures  12 months 
(+) Effects of 
HF QIC  Fair Fair 
Yes, some 
significant. 
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Benedetti, et al. 
(2004) 
12 clinical 
outcomes for 
diabetes care 
Baseline measurements (NS).  Control 
sites (none - study involves only a 
discussion of 1 site).  Standardization of 
outcomes (none).  Protection from bias 
(none mentioned).  Protection from 
secular changes (NS).  Unclear 
(+) Effects of 
collaborative on 
outcomes Poor Poor No. 
Chin, et al. 
(2004) 
Intermediate 
outcomes 
related to 
Diabetes 
mellitus care 
Baseline Measurements (done).  
Control sites (NS).  Characterization of 
selected sites (done).  Standardization 
of outcomes (done). Protection from 
bias (NS).  Protection from secular 
changes (NS).  12 months 
Inc. rates of 
HbA1c, 
podiatry/eye 
referrals, and 
lipid 
assessments. Fair Fair No 
Chin, et al. 
(2007) 
Numerous 
process-of-care 
and clinical 
outcomes 
measures. 
Baseline measurements (done).  
Control sites (no control group for 
primary before-after analysis).  
Characterization of selected sites 
(limited data).  Standardization of 
outcome measures (done).  Protection 
from bias (RCT - yes, CS - no).  Secular 
trends (discussed, not controlled for).   36 months 
(+) effects on a 
number of 
processes and 
outcomes of 
care. Fair Fair No 
Fox, et al. 
(2006)  
HF compliance, 
and AMI 
composite 
performance 
scores 
Baseline measurements (unclear - only 
two measures presented).  Control sites 
(state centers used as controls).  
Characterization of selected cites (NS).  
Standardization of outcome measures 
(done).  Protection from bias (limited - 
composite HF and AMI scores not 
defined, nor are complete data 
available).  Secular trends (NS).   24 months 
(+) Effects on 
ACEI 
prescribing 
patterns and 
HF/AMI 
outcomes. Poor Poor No 
Homer, et al. 
(2005) 
Primary and 
secondary 
asthma-related 
outcomes 
Baseline measurements (given, some 
detail).   Control sites (some 
differences).  Characterization of 
selected sites (done).  Standardization 
of outcomes measures (done).  
Protection from bias (randomization).   36 months 
No effect of 
intervention on 
pre-determined 
outcomes. Fair  Fair 
Yes, not 
significant 
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Landon, et al. 
(2007) 
Relevant 
Quality-of-care 
measures for 
Diabetes, 
Asthma, 
Hypertension 
Baseline Measurements (given).  
Control sites (yes, internal and external 
controls).  Characterization of selected 
sites (done).  Standardization of 
outcomes measures (yes).    Protection 
from bias (some sampling, 
measurement biases present).  Secular 
trends (discussed, unknown influence).   Variable* 
(+) Effects on 
prevention/scre
ening 
processes of 
care. No effect 
on clinical 
outcomes. Fair Good 
Yes, not 
significant 
Landon, et al. 
(2004) 
HIV-related 
process of care 
outcomes 
Baseline measurements (small 
differences).  Control sites (described). 
Characteristics of selected sites (given).  
Blinded assessment (NS).  
Randomization (no).  Protection from 
bias (statistical analytic techniques 
used minimize bias).  18 months 
No significant 
effects on 
quality of care Good Good No 
Mangione-
Smith, et al. 
(2005) 
Process-of-care 
and QOL 
outcomes 
Baseline measurements (some 
differences).  Control sites (selected by 
reputational process).  Blinded 
assessment (No).  Randomization (no).  
Protection from bias (measurement bias 
likely, esp. given non-blinded 
assessment. 12 months 
(+) Effects on 
selected 
processes of 
care Fair Poor 
Yes, not 
significant   
Schonlau, et al. 
(2005) 
11 Quality 
indicators and 4 
processes-of-
care 
measurements. 
Baseline measurements (none)  
Blinded assessment (yes).    
Characteristics of selected sites (info 
given for patients, but not for sites 
themselves). Randomization (no).  
Protection from bias (potential for 
selection bias based on site selection, 
also unknown confounders).  Secular 
trends (briefly discussed, no before-
after data available). 13 months 
(+) Effects on 
some quality 
indicators and 
processes of 
care Poor Poor 
Yes, not 
significant 
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Philbin, et al. 
(2000) 
Process-of-care 
and clinical 
outcomes 
Baseline measurements (small 
differences).  Blinded assessment (no).  
Characteristics of selected sites (given).  
Protection from bias (randomization).   
Secular trends (NS). 18 months 
No effect on 
most clinical 
outcomes.  
Non-significant 
reduction in 
hospital length-
of-stay in 
intervention 
group Good Fair 
Yes, not 
significant 
Siomos, et al. 
(2005) 
6 HEDIS quality 
of care 
measures for 
DM 
Baseline measurements (NS). Control 
sites (none).  Blinded assessment 
(none).  Randomization (no).  
Protection from bias (NS; high potential 
for selection bias; baseline 
measurements not presented).  Secular 
trends (not discussed).   
36 
months† 
No statistically 
significant 
effect on 
HEDIS 
diabetes care 
measures. Poor Poor No. 
* Exact time of site enrollment not available. 
† Composition of enrolled sites varied with year of study 
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Appendix 3: Further Methods 
 
Web-Based Survey 
We developed a web-based survey designed using Qualtrics Survey Software to 
validate themes and concepts uncovered in the in-depth interviews and identify new ones by 
increasing the representative nature of our analysis and the potential for quantitative data 
analysis by efficiently reaching larger numbers of informed respondents. Surveying all relevant 
ICN participants, i.e. the entire ICN member population, allowed maximum power of our results.  
To capture the entire but limited universe of ICN participants, we asked experts in survey 
methodology and those with expertise in gastroenterology to review our survey rather than 
conduct a pilot. Expert reviewers included Anthony Viera (family physician and survey expert) 
and Greg Randolf (quality improvement expert in clinical settings). We provided the reviewers 
with a brief introduction of our study and the goals of the survey with an emphasis that to pilot 
the user groups would sacrifice our universe of participants, and asked them for critical 
feedback to improve the survey. Once we incorporated experts‟ feedback, we asked two ICN 
members, Sandra Kim, MD, from University of North Carolina-Chapel Hill, and Amy Donegan, 
NP, from Nationwide Children‟s Hospital in Columbus, OH, to evaluate the survey for clarity of 
questions and response options and ease of completion. We released the final survey to the 
ICN universe on June 2, 2010, and sent reminders to non-responders weekly for two weeks 
after the survey release. The final survey is presented in Appendix 6   
We uploaded survey results from Qualtrics to an Excel spreadsheet to tabulate 
descriptive statistics. Response rate was calculated. We quantified themes and concepts 
addressed by the survey and compared them to those uncovered in the qualitative interviews.  
 
Observation of Participants at an ICN Learning Session 
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We observed collaborative members at one of ICN's biannual learning sessions in Chicago, IL 
on April 9-11, 2010. The three-day session included an introductory day-long session for new 
centers joining the collaborative and two days of learning and research activities for all ICN 
members. We observed and recorded notes of participant activities as well as their interactions.  
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Figure A-3: Search Approach for Chronic Disease Collaborative Literature 
 
 
Inclusion criteria: Articles written about collaboratives targeted at one or more chronic diseases, met the definition 
of collaborative, took place in the U.S., and written in English. Definition of a collaborative: a voluntary network of 
health care providers in more than one health care system who agree to share data and information on processes 
of care for the purposes of improving quality of care and patient outcomes. 
Exclusion criteria: Articles about collaboratives (1) in settings of emergency departments, surgery, intensive care 
units, and general primary care without a specific disease focus; (2) focusing on organ donation, cancer screening, 
medical imaging, and palliative care.  
 
MEDLINE Advanced Search Terms:  
“quality” *all fields+ AND (“cooperative behavior” [MeSH Terms] OR “cooperative” *all fields+ AND 
“behavior” *all fields+ OR “collaborative” *all fields+) AND “improvement” *all fields+  
Limits: “humans” *MeSH Terms+ AND English *lang+ 
Date of Search: January 9, 2010 
Yield: 626 articles 
 
51 Articles meeting criteria, 
+ 
5 Articles meeting criteria from hand-
searched references 
Yield: 56 articles  
Inclusion Criteria: Studies addressing patient-oriented outcomes   
Exclusion criteria: Studies evaluating effective components of collaborative, i.e. teamwork or information 
technology, and studies examining exclusively non-disease specific outcomes. 
ield: 13 articles 
Process/Methods: 
19 articles 
  
Effectiveness: 
22 articles 
  
Sustainability: 
15 articles 
  
Yield: 13 articles 
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Appendix 4: Interview Protocol for Existing Sites 
 
ImproveCareNow (ICN) Pediatric IBD Collaborative:  Investigation into the Causes of 
Outcomes Improvement 
 
Fact Sheet/Interview Protocol/Script for in-depth interviews with key informants at 6 to 10 
participating institutions. 
[Introductory script, embedding study information and agreement to participate:] 
Hello, I am [Erica Peterson/Thomas Runge]. Thank you so much for talking with me today.  As 
you recall, I am one of the two research assistants working with Dr. Michael Kappelman and Dr. 
Sue Tolleson-Rinehart at the University of North Carolina to help evaluate improvement 
processes in the ImproveCareNow Collaborative.   
I am a medical student who is also earning the Master of Public Health degree at UNC.  Drs. 
Kappelman and Tolleson-Rinehart hope that this study of improvement processes at ICN will 
also become the subject of my master‟s paper, and my fellow student‟s master‟s paper. 
We are interviewing collaborative members.  As we mentioned in our initial e-mail message, this 
interview contains several open-ended questions, and should last around 30 minutes, 
depending on the time you have to give and what you want to tell me.  We ask your permission 
to record the interview in order to assure we capture all you have to say as accurately as 
possible.  We will be furnishing you with a transcript of your interview, and will welcome any 
additional information you want to add to that. 
The intent of this study is to help the ICN Collaborative measure and understand what its 
improvement processes are accomplishing.  We do intend to use the data to complete two 
master‟s papers, and we will try to publish those papers in the literature.  We will, of course, be 
making all findings available to the ICN Collaborative for its use.  You and your institution will be 
anonymous, but we do wish to use direct quotes from your interview. 
The ICN Collaborative Research Committee agrees to support the project, and the UNC IRB 
has determined that we are exempt. (IRB exemption # 09-2172).  Please don‟t hesitate to ask 
any questions about the project – you may contact Dr. Kappelman at 
Michael_Kappelman@med.unc.edu or Dr. Tolleson-Rinehart at suetr@unc.edu.   
Before we continue, would you please give me a verbal agree to the statements I‟m about to 
read?   
   I AGREE to having this interview tape recorded with a digital voice recorder.   
   I GIVE PERMISSION for the use of direct quotes from this interview for purposes of 
analysis. 
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Now we are ready to begin! 
1. First, we wanted to ask you your general impression of collaboratives, and what do you 
think motivates institutions to participate in them? 
 
2. And thinking about ICN particularly, what about participating in it has been most valuable 
to you as a health care provider who cares for children with IBD. 
 
3.   Now we would like to focus on specific ICN quality improvement activities. 
3.a. First, just off the top of your head, can you give me a list of all the activities the 
ICN has started?   
[If respondent does not understand, say “That is, just whatever comes to mind when you 
think of the initiatives or practice changes you are involved in because of ICN.”] 
3.b. And which of those things do you think have gone well? 
3.c. And which of those things do you think have not been so successful? 
 
4.  The next questions focus on the things YOU and YOUR INSTITUTION have done as a 
result of your participation in ICN.  Could you start by listing the changes that have been made 
at your institution as a result of the collaborative.  
 
5. To respect your time, we want to focus on what you think have been the most important 
things you‟ve mentioned – the ones you think have been most important in driving improvement 
at your institution.   
In each case, we want to know your institution‟s experience. 
5.a.  Which of the list you just gave me is the most important thing? 
[do repeat back] 
5.b. For [first thing,], can you describe it in more detail?  That is, tell me about how you 
put it into place at your institution, and how it went?  
 
[CHECKPOINTS:  if they DO NOT mention these things, go back and ask…] 
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 And when did that happen? 
 How long did it take to get it going? 
 What did you expect it would produce? 
 And about when did you expect to see results from it? 
 And where does it stand now?  Is it successful and ongoing?  Still being 
implemented?  Did it stop? 
 
 
6. [second thing] 
7. [third thing] 
8.  [fourth thing] 
 
Okay, thank you so much!  We are nearly done. 
 
Clearly, your commitment to the collaborative is strong – you have invested time and energy in 
it.  Thanks for telling me about your clinic. We also know from the data that outcomes appeared 
to have improved.  With that understood, we want to ask you to step back and think about how 
improvement happens in two last questions. 
 
9. First, do you think the outcomes improvement is a result of collaborative activity?  
[Pause] That is, do you think that the collaborative is already paying dividends, or that it is still 
too soon to have seen the effects on patient outcomes, or somewhere in between?   
 
10. Thank you for telling me about your clinic. Last, I‟d like to ask you are there other 
changes that have occurred at your institution/center that may have affected outcomes (as 
measured by the collaborative database)?  
[Can you think of other changes that would have produced these results, such as changes in 
your center's provider and/or payor mix, leadership, etc.] 
 
Thank you!  That ends the interview.  We will be sending you a transcript soon!  Is there 
anything else you would like to tell us? 
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Appendix 5: Interview Protocol for New Sites 
 
ImproveCareNow (ICN) Pediatric IBD Collaborative: Investigation into the Causes of 
Outcomes Improvement 
 
Fact Sheet/Interview Protocol/Script for in-depth interviews with key informants at 2 to 3 new 
institutions. 
 
 
[Introductory script, embedding study information and agreement to participate:] 
 
Hello, I am [Erica Peterson/Thomas Runge]. Thank you so much for talking with me today.  As 
you recall, I am one of the two research assistants working with Dr. Michael Kappelman and Dr. 
Sue Tolleson-Rinehart at the University of North Carolina to help evaluate improvement 
processes in the ImproveCareNow Collaborative.   
 
I am a medical student who is also earning the Master of Public Health degree at UNC.  Drs. 
Kappelman and Tolleson-Rinehart hope that this study of improvement processes at ICN will 
also become the subject of my master‟s paper, and my fellow student‟s master‟s paper. 
 
We are interviewing collaborative members.  As we mentioned in our initial e-mail message, this 
interview contains several open-ended questions, and should last around 30 minutes, 
depending on the time you have to give and what you want to tell me.  We ask your permission 
to record the interview in order to assure we capture all you have to say as accurately as 
possible.  We will be furnishing you with a transcript of your interview, and will welcome any 
additional information you want to add to that. 
 
The intent of this study is to help the ICN Collaborative measure and understand what its 
improvement processes are accomplishing.  We do intend to use the data to complete two 
master‟s papers, and we will try to publish those papers in the literature.  We will, of course, be 
making all findings available to the ICN Collaborative for its use.  You and your institution will be 
anonymous, but we do wish to use direct quotes from your interview. 
 
The ICN Collaborative Research Committee agrees to support the project, and the UNC IRB 
has determined that we are exempt. (IRB exemption # 09-2172).  Please don‟t hesitate to ask 
any questions about the project – you may contact Dr. Kappelman at 
Michael_Kappelman@med.unc.edu or Dr. Tolleson-Rinehart at suetr@unc.edu.   
 
Before we continue, would you please give me a verbal agree to the statements I‟m about to 
read?   
 
   I AGREE to having this interview tape recorded with a digital voice recorder.   
 
   I GIVE PERMISSION for the use of direct quotes from this interview for purposes of 
analysis. 
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Now we are ready to begin! 
 
1. First, we wanted to ask you your general impression of collaboratives? What do you 
think motivates institutions in general to participate in them? 
 
 
1.a. And what made you and your institution interested in participating in these kinds 
of activities? 
 
 
2. And thinking about your joining ICN particularly, what do you expect will be most 
valuable to you as a health care provider who cares for children with IBD?  
 
[That is, what improvements do you hope to see through your participation in ICN?] 
 
 
3.   Now, we would like to focus specifically on quality improvement activities.  
 
3.a. Are there any particular activities you have already started at your clinic to 
improve the quality of care for your patients? 
 
 
[If yes,]  
3.b. And which of those things do you think have gone well? 
 
 
3.c. And which of those things do you think have not been so successful? 
 
 
4.  What are the challenges/obstacles you face in implementing quality improvement 
activities?  
 
 
Okay, thank you so much!  We are nearly done: 
 
In our final question, we want to ask you to step back and think about how quality improvement 
happens. As you may know, ICN collects various data, including certain patient outcomes. 
 
 
5. What factors do you think are important for measuring outcomes improvement?  
 
 
 
Thanks for telling me about your clinic and your expectations in participating in ICN. That ends 
the interview.  We will be sending you a transcript soon!  Is there anything else you would like to 
tell us? 
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Appendix 6: Web-Based Survey 
 
1. We can determine when all sites joined ICN, but we are interested in when YOU think YOUR 
site became fully engaged in ICN and its activities.  Please estimate the year you think your 
center became fully engaged. 
a) 2007 
b) 2008 
c) 2009 
d) 2010 
e) Our center is not yet fully engaged 
 
2. What types of health professionals are involved with IBD patients in your pediatric IBD 
program (not necessarily as a part of ICN)?   Select all that apply. 
a) Physicians 
b) Mid-level providers (PAs, NPs, etc.) 
c) Nurses 
d) Clinical pharmacists who are assigned to the program 
e) Nurses assistants or medical assistants 
f) Nutritionists, dietitians 
g) Psychologists or psychiatrists 
h) Social workers 
i) Financial counselor 
j) Other:   Please specify   ___________ 
 
3. What best describes you? If you have more than one role, please choose the one that is most 
applicable right now, to the pediatric IBD program at your center. 
a) I am a physician who cares for patients with IBD 
b) I am a mid-level provider (NP, PA) 
c) I am a pharmacist 
d) I am a nurse 
e) I am a dietitian 
f) I am a research assistant 
g) I am a quality improvement specialist  
h) Other:   Please specify   ___________ 
 
3a. Please estimate what fraction of your total IBD patient population is actively followed in the 
ICN database (e.g. most visits for these patients are entered) 
a) Less than 20% 
b) Between 20% and 40% 
c) Between 40% and 60%  
d) Between 60% and 80% 
e) More than 80% 
f) Unable to estimate 
 
4.  The statements below are a list of things people have told us about why the ICN 
collaborative is important to them.  Please use the slider bars (0-10) below to tell us how 
important or unimportant each of these things is to YOU and YOUR involvement in ICN.  If 
something does not matter to you AT ALL, please drag the slider bar to zero. 
a) Using quality improvement strategies to help patients 
 0 1 2 3 4 5 6 7 8 9 10 
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b) Helping health care providers learn leadership skills 
 
c) Working together and sharing with providers at other centers 
 
d) An opportunity for research 
 
e) Developing, agreeing to, and using best practice standards 
 
f) Other - Please specify. 
 
 
 
5.  As a health care provider, what has been (or what do you expect to be) the SINGLE most 
valuable aspect of being a member in ImproveCareNow? 
a) Using quality improvement strategies to help patients 
b) Helping health care providers learn leadership skills 
c) Working together and sharing with providers at other centers 
d) An opportunity to do research 
e) Developing, agreeing to, and using best practice standards 
f) Other:   Please specify   ___________ 
 
6.  If you have used any of the following activities, please move the slider bars below to rate 
each of the following according to HOW VALUABLE THEY ARE to improving the care of IBD 
patients at your center.   
If things are NOT VALUABLE at all, please move the slider bar to zero, to make sure your 
choice registers. 
If you have NEVER DONE an activity, check the box “Not Applicable.” 
In the “other” option, if you have no additional comments, please select “Not applicable.” 
a) Standardized IBD Clinic Template 
 
b) Model Care Guidelines 
 
c) Nutrition/Growth Algorithms 
 
d) Dedicated IBD Clinic 
 
e) Monthly Narrative Reports submitted to ICN 
 
f) Running small tests of change (PDSAs) at your site 
 
g) Pre-visit planning 
 
h) Regular meetings to discuss patients from Population Management Reports (PMR) 
 
i) Multidisciplinary team meetings, other than those used to discuss PMR 
 
j) Real-time process auditing 
 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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k) Patient self-management support (e.g. education sessions, support groups, materials) 
 
l) Other – Please specify  
 
 
 
7.  ICN provides several services and educational opportunities to its sites.  Now we‟d like you 
to rate the value of each of the following.  IF YOU HAVE USED any of the following activities, 
please MOVE the slider bars below to rate each according to HOW VALUABLE THEY ARE to 
improving the care of IBD patients at your center.  
If things are not valuable at all, please move the slider bar to zero, to be sure your choice 
registers. 
If you HAVE NEVER USED an activity, check the box “Not Applicable.” 
In the “Other” option, if you have no additional comments, please select “Not applicable.” 
a) Conference calls and webinars 
 
b) Email/Listserv 
 
c) Extranet 
 
d) Monthly data reporting from ICN 
 
e) Population management reports 
 
f) Semi-annual Learning Sessions 
 
g) Other – please describe. 
 
 
8. Below are some potential obstacles to participation in ICN.   Please use the slider bars to 
indicate how challenging these factors are, at your center.  If one or more of these is NOT a 
challenge for your site, please move the slider bar to zero.   
If you don‟t know or cannot assess, please check the box “Not Applicable.” 
In the “Other” option, if you have no additional comments, please select “Not Applicable." 
a) Financial Costs 
 
b) It takes my time 
 
c) It takes the time of other staff 
 
d) It takes time to see change 
 
e) Clinic restructuring 
 
f) Transition to electronic medical records (EMR), or other changes to medical record 
 
g) Turnover of specific, key personnel 
 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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h) Lack of leadership commitment to ICN, or QI in general. 
 
i) Difficulty changing the practices of physicians, nurses, and staff 
 
j) Other – Please specify. 
 
 
9. Finally, please address the relative effect of each of the variables below on improved patient 
outcomes in ICN, since 2007.  Please MOVE the slider bars below to rate each of the following 
according to HOW IMPORTANT THEY ARE to improving patient outcomes. 
If things are NOT IMPORTANT at all, please MOVE the slider bar to zero, to be sure your 
choice registers. 
If you don‟t know or cannot assess, please check the box “Not Applicable.” 
In the “OTHER” column, if you have no additional comments, please select “Not Applicable.” 
a) Improved medication management, as a result of scientific or therapeutic advances. 
 
b) Continuing education about IBD, independent of ICN 
 
c) Other secular trends, that is, changes in medicine generally that affect all practices 
 
d) Natural stabilization of the course of disease over time, occurring idnependent of ICN 
 
e) Other changes in your practice (addition or loss of key physicians, nurses, or other staff) 
 
f) New patient-parent support mechanisms unrelated to ICN 
 
g) Variation in scoring of the PGA (Physician Global Assessment) 
 
h) How patients were entered into the database (i.e., early on, sicker patients more likely to 
be entered due to frequency of clinic visits compared to healthier patients) 
 
i) The ImproveCareNow collaborartive intervention 
 
j) Other – Please specify. 
 
 
 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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